All comments shall be forwarded to [email protected]. no later until 10 July 2020.
The general objective of this Circular is to provide a clear and consistent procedure for the safety of FDA employees and clients in order to prevent the spread of infectious diseases such as COVID-19 in the workplace.
Specifically, it aims to:
2.1 Limit foot traffic;
2.2 Limit face to face interaction by encouraging online transactions.
to continue reading, click the attachment below…